We support the development of your small molecule parenteral product
While the number of biopharmaceutical compounds is rapidly growing, most therapeutic compounds on the market and in development are small molecules. They are used in a huge variety of therapeutic and diagnostic applications in all relevant fields of medicine.
Small molecules for parenteral applications are preferable formulated in aqueous solutions. However, small chemical compounds may exhibit poor water solubility and require a dedicated formulation development alongside chemical adjustments to achieve sufficiently high concentrations. Coriolis is specialized in developing tailored liquid as well as lyophilized formulations. With our large analytical portfolio, we characterize the stability and integrity of your small molecule drug substance.
Development services for your small molecule product
Explore our large portfolio of development services. In a unique collaborative approach, we tailor each study to your needs and your current development phase. You will benefit from the scientific experience of our expert scientists and meet your development goals faster and with a higher chance of success.
Analytical services for your small molecule product
Choose from a large set of analytical techniques in a variety of categories or get our expert opinion on the most suitable methods for your analytical challenge. We offer standardized analytical methods for many common sample types and perform dedicated method development specific for your analytical challenge and drug product. Explore our analytical portfolio ranging from discovery phase analysis to lot release testing methods.
Other product types
We tailor our services to your specific product type and development phase. In a unique collaborative approach, our expert scientists focus on your scientific question or development milestone and support your drug development program with their many years of experience. Select your product type to learn more about our services.